The Hindu Business Line : Haffkine Bio mulls ventures for vaccines

The Haffkine Bio-pharmaceutical Corporation Ltd (HBCL), a public sector company, is seeking a partnership with a private sector player for setting a joint venture for producing new age vaccines.

It wants to create a Rs 40-crore joint venture company in which it is ready to invest Rs 10 crore, said Dr Ravindra Bapat, Chairman, HBCL. He was addressing the media here on Wednesday. Dr Bapat said through the joint venture, the company wants to enter the new age tissue culture vaccine market. HBCL foresees a good market for measles, diphtheria, polio, typhoid and Hepatitis vaccines.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Chemplast to invest in Mettur plant

Toyota launches Innova variant

PTL forays into healthcare — Artemis to set up 500-bed hospital in Gurgaon

ICAI southern region secy

Megasoft scouting to buy US co

Sri Biotech makes plans for Rs 2-cr facility

Apollo plans oncology centre in Ahmedabad

HPCL Punjab refinery financial closure by May

John Crane manufacturing centre

Dunlop talks stumble — Productivity norms prove contentious

Hikal in drug supply pact with Degussa

Haffkine Bio mulls ventures for vaccines

Concern over sick industrial units in AP

TACO MobiApps to enter China, Asean — Chalks expansion plan for domestic market

`Exide not hit by rising lead prices'